Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors

PLoS One. 2015 Mar 6;10(3):e0116316. doi: 10.1371/journal.pone.0116316. eCollection 2015.

Abstract

Background: Although 5-HTTLPR has been shown to influence the risk of life stress-induced depression in the majority of studies, others have produced contradictory results, possibly due to weak effects and/or sample heterogeneity.

Methods: In the present study we investigated how age, type and intensity of life-stressors modulate the effect of 5-HTTLPR on depression and anxiety in a European population cohort of over 2300 subjects. Recent negative life events (RLE), childhood adversity (CHA), lifetime depression, Brief Symptoms Inventory (BSI) depression and anxiety scores were determined in each subject. Besides traditional statistical analysis we calculated Bayesian effect strength and relevance of 5-HTTLPR genotypes in specified models.

Results: The short (s) low expressing allele showed association with increased risk of depression related phenotypes, but all nominally significant effects would turn to non-significant after correction for multiple testing in the traditional analysis. Bayesian effect strength and relevance analysis, however, confirmed the role of 5-HTTLPR. Regarding current (BSI) and lifetime depression 5-HTTLPR-by-RLE interactions were confirmed. Main effect, with other words direct association, was supported with BSI anxiety. With more frequent RLE the prevalence or symptoms of depression increased in ss carriers. Although CHA failed to show an interaction with 5-HTTLPR, in young subjects CHA sensitized towards the depression promoting effect of even mild RLE. Furthermore, the direct association of anxiety with the s allele was driven by young (≤30) individuals.

Limitations: Our study is cross-sectional and applies self-report questionnaires.

Conclusions: Albeit 5-HTTLPR has only weak/moderate effects, the s allele is directly associated with anxiety and modulates development of depression in homogeneous subgroups.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors*
  • Cohort Studies
  • Cross-Sectional Studies
  • Depression / etiology
  • Depression / genetics*
  • Europe
  • Female
  • Genetics, Population*
  • Humans
  • Life Change Events*
  • Male
  • Serotonin Plasma Membrane Transport Proteins / genetics*
  • Stress, Psychological / complications

Substances

  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins

Grants and funding

The study was supported by the Sixth Framework Program of the European Union, NewMood, LSHM-CT-2004-503474; by the National Institute for Health Research Manchester Biomedical Research Centre; the TAMOP-4.2.1.B-09/1/KMR-2010-0001; by the Hungarian Brain Research Program (Grant KTIA_13_NAP-A-II/14) and National Development Agency (Grant KTIA_NAP_13-1-2013-0001); the Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group). Dr. Gonda is a recipient of the Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.